Daniel J. Odenheimer

Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor‐2) to accelerate wound healing in venous ulcers

Martin C. Robson, Tania J. Phillips, Vincent Falanga et al. · Wound Repair and Regeneration · 2001 · 173 citations

Veterinary Medicine, Pharmacotherapy, Surgery +16

Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial

William J. Sandborn, Bruce E. Sands, Douglas C. Wolf et al. · Alimentary Pharmacology & Therapeutics · 2003 · 114 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

Phase I/II Randomized Trial Evaluating the Safety and Clinical Effects of Repifermin Administered to Reduce Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

César O. Freytes, Voravit Ratanatharathorn, Charles Taylor et al. · Clinical Cancer Research · 2004 · 69 citations

Pharmacy, Pharmacotherapy, Cell Therapy +16

Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats.

Peter Coyle, Daniel J. Odenheimer, Charles F. Sing · Stroke · 1984 · 60 citations · Full text

Life Sciences, Genetics, Neuroscience +15

The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia

Daniel J. Odenheimer, Sharada A. Sarnaik, Charles F. Whitten et al. · American Journal of Medical Genetics · 1987 · 36 citations · Full text

Medicine, Hematology, Pediatrics +15